{"transactions":[{"id":725548,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-27T01:20:56.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":47675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the total number of shares of common stock subject to the option vest monthly following the date of grant, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":47675,"derivative":{"exercise_price":21.81,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":47675},"source":{"system":"sec-edgar","filing":"0001193125-26-286434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000119312526286434/ownership.xml","form_type":"4"}},{"id":730652,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-22T20:15:07.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":51000,"derivative":{"exercise_price":3.62,"expiration_date":"2036-06-17","underlying":"Class A Ordinary Shares","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001834161-26-000008","document":"form4-06222026_040603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000183416126000008/form4-06222026_040603.xml","form_type":"4"}},{"id":879709,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:55:19.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":1889,"price":9.82,"value":18549.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025."}],"balance_after":154024,"source":{"system":"sec-edgar","filing":"0001628280-26-012394","document":"wk-form4_1772142916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026012394/wk-form4_1772142916.xml","form_type":"4"}},{"id":879708,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:55:19.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":1616,"price":9.5326,"value":15404.6816,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":155913,"source":{"system":"sec-edgar","filing":"0001628280-26-012394","document":"wk-form4_1772142916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026012394/wk-form4_1772142916.xml","form_type":"4"}},{"id":885210,"issuer":{"id":5413,"kind":"organization","name":"Zura Bio Ltd"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-02-25T02:14:02.000Z","date":"2026-02-21","kind":"grant","planned":false,"acquired":true,"shares":37812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in twelve substantially equal monthly installments over a one-year period measured from February 21, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":37812,"derivative":{"exercise_price":6.53,"expiration_date":"2036-02-21","underlying":"Class A Ordinary Shares","underlying_shares":37812},"source":{"system":"sec-edgar","filing":"0001834161-26-000006","document":"form4-02252026_020259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855644/000183416126000006/form4-02252026_020259.xml","form_type":"4"}},{"id":885005,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2026-02-25T00:11:29.000Z","date":"2026-02-22","kind":"grant","planned":true,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":110000,"derivative":{"exercise_price":7.56,"expiration_date":"2036-02-21","underlying":"Common  Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001628280-26-011329","document":"wk-form4_1771978287.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011329/wk-form4_1771978287.xml","form_type":"4"}},{"id":885004,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-25T00:11:29.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":2089,"price":7.4528,"value":15568.8992,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":157529,"source":{"system":"sec-edgar","filing":"0001628280-26-011329","document":"wk-form4_1771978287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011329/wk-form4_1771978287.xml","form_type":"4"}},{"id":885003,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-25T00:11:29.000Z","date":"2026-02-22","kind":"grant","planned":true,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":159618,"source":{"system":"sec-edgar","filing":"0001628280-26-011329","document":"wk-form4_1771978287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011329/wk-form4_1771978287.xml","form_type":"4"}},{"id":1085548,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-17T22:46:56.000Z","date":"2025-07-17","kind":"sale","planned":true,"acquired":false,"shares":3586,"price":5.4738,"value":19629.0468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.41 to $5.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":104618,"source":{"system":"sec-edgar","filing":"0001628280-25-035269","document":"wk-form4_1752792412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025035269/wk-form4_1752792412.xml","form_type":"4"}},{"id":1085547,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-17T22:46:56.000Z","date":"2025-07-15","kind":"sale","planned":true,"acquired":false,"shares":6796,"price":5.4682,"value":37161.8872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":108204,"source":{"system":"sec-edgar","filing":"0001628280-25-035269","document":"wk-form4_1752792412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025035269/wk-form4_1752792412.xml","form_type":"4"}},{"id":1246308,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2025-02-25T20:39:08.000Z","date":"2025-02-22","kind":"grant","planned":true,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":80000,"derivative":{"exercise_price":9.57,"expiration_date":"2035-02-21","underlying":"Common  Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001628280-25-007699","document":"wk-form4_1740515940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025007699/wk-form4_1740515940.xml","form_type":"4"}},{"id":1246307,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-25T20:39:08.000Z","date":"2025-02-22","kind":"grant","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":115000,"source":{"system":"sec-edgar","filing":"0001628280-25-007699","document":"wk-form4_1740515940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025007699/wk-form4_1740515940.xml","form_type":"4"}},{"id":1453748,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical  Officer"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2024-07-16T20:40:36.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vest and become exercisable on July 15, 2025, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":150000,"derivative":{"exercise_price":9.37,"expiration_date":"2034-07-14","underlying":"Common  Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-24-083951","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000095017024083951/ownership.xml","form_type":"4"}},{"id":1453747,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical  Officer"}}],"security":"Common Stock","published_at":"2024-07-16T20:40:36.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0000950170-24-083951","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000095017024083951/ownership.xml","form_type":"4"}},{"id":1785133,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-08T20:59:29.000Z","date":"2023-09-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1860,"price":0.9631,"value":1791.366,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":159917,"source":{"system":"sec-edgar","filing":"0001209191-23-048809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123048809/doc4.xml","form_type":"4"}},{"id":1787949,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-09-07T00:55:16.000Z","date":"2023-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1085,"price":1.06,"value":1150.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":161777,"source":{"system":"sec-edgar","filing":"0001209191-23-048555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123048555/doc4.xml","form_type":"4"}},{"id":1861257,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-09T23:12:06.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":2042,"price":17.038,"value":34791.596,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":162862,"source":{"system":"sec-edgar","filing":"0001209191-23-036054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123036054/doc4.xml","form_type":"4"}},{"id":1868126,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-06-05T20:22:12.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":1090,"price":18.83,"value":20524.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":164904,"source":{"system":"sec-edgar","filing":"0001209191-23-034288","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123034288/doc4.xml","form_type":"4"}},{"id":1924134,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-04-06T20:32:26.000Z","date":"2023-04-04","kind":"sale","planned":false,"acquired":false,"shares":9182,"price":18.7838,"value":172472.8516,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":165994,"source":{"system":"sec-edgar","filing":"0001209191-23-023592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123023592/doc4.xml","form_type":"4"}},{"id":1959578,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:55:04.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":6255,"price":20.1973,"value":126334.1115,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I."}],"balance_after":175176,"source":{"system":"sec-edgar","filing":"0001209191-23-018063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123018063/doc4.xml","form_type":"4"}},{"id":1959577,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:55:04.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":3885,"price":20.1973,"value":78466.5105,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I."}],"balance_after":181431,"source":{"system":"sec-edgar","filing":"0001209191-23-018063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123018063/doc4.xml","form_type":"4"}},{"id":1959576,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:55:04.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":12451,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares released for PSU TSR Grant vested on March 8, 2023."}],"balance_after":185316,"source":{"system":"sec-edgar","filing":"0001209191-23-018063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123018063/doc4.xml","form_type":"4"}},{"id":1959575,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:55:04.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":7732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023."}],"balance_after":172865,"source":{"system":"sec-edgar","filing":"0001209191-23-018063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123018063/doc4.xml","form_type":"4"}},{"id":1959574,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-11T02:55:04.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":7363,"price":21.1559,"value":155770.8917,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":165133,"source":{"system":"sec-edgar","filing":"0001209191-23-018063","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123018063/doc4.xml","form_type":"4"}},{"id":1970099,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-06T21:59:26.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":1187,"price":21.87,"value":25959.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":172496,"source":{"system":"sec-edgar","filing":"0001209191-23-016362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123016362/doc4.xml","form_type":"4"}},{"id":1997060,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-24T01:38:25.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":55000,"derivative":{"exercise_price":22.6,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-23-012425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123012425/doc4.xml","form_type":"4"}},{"id":1997059,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-24T01:38:25.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":173683,"source":{"system":"sec-edgar","filing":"0001209191-23-012425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919123012425/doc4.xml","form_type":"4"}},{"id":2099048,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-02T22:41:35.000Z","date":"2022-12-01","kind":"tax_withholding","acquired":false,"shares":1084,"price":15.04,"value":16303.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":141183,"source":{"system":"sec-edgar","filing":"0001209191-22-059472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122059472/doc4.xml","form_type":"4"}},{"id":2145871,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-10-04T21:21:59.000Z","date":"2022-09-30","kind":"tax_withholding","acquired":false,"shares":6777,"price":13.01,"value":88168.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":142267,"source":{"system":"sec-edgar","filing":"0001209191-22-052381","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122052381/doc4.xml","form_type":"4"}},{"id":2168158,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-02T21:30:47.000Z","date":"2022-09-01","kind":"tax_withholding","acquired":false,"shares":756,"price":13.09,"value":9896.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":149044,"source":{"system":"sec-edgar","filing":"0001209191-22-048555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122048555/doc4.xml","form_type":"4"}},{"id":2245960,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-06-03T20:21:52.000Z","date":"2022-06-01","kind":"tax_withholding","acquired":false,"shares":1141,"price":9.61,"value":10965.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":149800,"source":{"system":"sec-edgar","filing":"0001209191-22-034041","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122034041/doc4.xml","form_type":"4"}},{"id":2311821,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-04-01T23:28:25.000Z","date":"2022-03-31","kind":"tax_withholding","acquired":false,"shares":6442,"price":12.02,"value":77432.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":150941,"source":{"system":"sec-edgar","filing":"0001209191-22-022095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122022095/doc4.xml","form_type":"4"}},{"id":2356792,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-03T21:04:33.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":756,"price":13.62,"value":10296.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":157383,"source":{"system":"sec-edgar","filing":"0001209191-22-015366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122015366/doc4.xml","form_type":"4"}},{"id":2392770,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T02:01:33.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option will vest on March 1, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":100000,"derivative":{"exercise_price":15.6,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-010452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122010452/doc4.xml","form_type":"4"}},{"id":2392769,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-17T02:01:33.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2023, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":158139,"source":{"system":"sec-edgar","filing":"0001209191-22-010452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122010452/doc4.xml","form_type":"4"}},{"id":2445591,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-05T21:44:04.000Z","date":"2022-01-03","kind":"tax_withholding","acquired":false,"shares":7043,"price":14.82,"value":104377.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":98139,"source":{"system":"sec-edgar","filing":"0001209191-22-001743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919122001743/doc4.xml","form_type":"4"}},{"id":2487122,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-03T21:03:42.000Z","date":"2021-12-01","kind":"tax_withholding","acquired":false,"shares":4338,"price":12.65,"value":54875.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units."}],"balance_after":105182,"source":{"system":"sec-edgar","filing":"0001209191-21-067780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919121067780/doc4.xml","form_type":"4"}},{"id":2547541,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-06T23:25:59.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":44520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent of the shares subject to the option vests on each September 30, 2022 and March 31, 2023."}],"balance_after":44520,"derivative":{"exercise_price":9.93,"expiration_date":"2031-10-04","underlying":"Common Stock","underlying_shares":44520},"source":{"system":"sec-edgar","filing":"0001209191-21-059869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919121059869/doc4.xml","form_type":"4"}},{"id":2547540,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-06T23:25:59.000Z","date":"2021-10-04","kind":"grant","acquired":true,"shares":74520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on each December 31, 2021, March 31, 2022, September 30, 2022 and March 31, 2023."}],"balance_after":109520,"source":{"system":"sec-edgar","filing":"0001209191-21-059869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919121059869/doc4.xml","form_type":"4"}},{"id":2959314,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Incoming Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-03T23:51:20.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent of the shares subject to the option vest on December 1, 2021 and the remainder vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":80000,"derivative":{"exercise_price":41.25,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-20-061651","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120061651/doc4.xml","form_type":"4"}},{"id":2959313,"issuer":{"id":7431,"kind":"organization","name":"KYNTRA BIO, INC.","symbol":"KYNB"},"owners":[{"id":35162,"kind":"person","name":"Eisner Mark","position":1,"cik":"0001834161","reported_name":"Eisner Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Incoming Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-12-03T23:51:20.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on December 1, 2021, and the remainder vest in equal amounts quarterly thereafter for the following three years."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001209191-20-061651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921299/000120919120061651/doc4.xml","form_type":"4"}}]}